DE1215161B - Process for the preparation of 2-aminopyrimidines substituted in the 5-position - Google Patents
Process for the preparation of 2-aminopyrimidines substituted in the 5-positionInfo
- Publication number
- DE1215161B DE1215161B DESCH29319A DESC029319A DE1215161B DE 1215161 B DE1215161 B DE 1215161B DE SCH29319 A DESCH29319 A DE SCH29319A DE SC029319 A DESC029319 A DE SC029319A DE 1215161 B DE1215161 B DE 1215161B
- Authority
- DE
- Germany
- Prior art keywords
- alkyl group
- reaction
- preparation
- general formula
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
DEUTSCHESGERMAN
PATENTAMTPATENT OFFICE
AUSLEGESCHRIFTEDITORIAL
Int. α.:Int. α .:
C07dC07d
Deutsche Kl.: 12 ρ - 7/01 German class: 12 ρ - 7/01
Nummer: 1215 161Number: 1215 161
Aktenzeichen: Sch 29319IV d/12 ρFile number: Sch 29319IV d / 12 ρ
Anmeldetag: 2. März 1961Filing date: March 2, 1961
Auslegetag: 28. April 1966Opening day: April 28, 1966
Gegenstand des Hauptpatents 1145 622 ist ein Verfahren zur Herstellung von 5-Arkoxy-2-aminopyrimidinen der allgemeinen FormelThe main patent 1145 622 relates to a process for the preparation of 5-arkoxy-2-aminopyrimidines the general formula
NH2 NH 2
worin R eine niedere Alkylgruppe bedeutet, durch Umsetzung von 1,1,2-Trialkoxyäthanen der allgemeinen Formelwherein R is a lower alkyl group, by reacting 1,1,2-trialkoxyethanes of the general formula
— CH2 — CH(OR')2 - CH 2 - CH (OR ') 2
IIII
:n —CHO: n —CHO
IIIIII
worin R1 und R2 Alkylreste und R2 außerdem auch einen Phenylrest bedeuten, Vollziehung der Vilsmeier-Kondensation im oben angegebenen Temperaturbereich und Umsetzung des so erhaltenen Reaktionsgemisches mit der Lösung eines Guanidinsalzes und Alkalihydroxyd oder Alkalialkanolat in einem niederen Alkohol.where R 1 and R 2 are alkyl radicals and R 2 is also a phenyl radical, completion of the Vilsmeier condensation in the temperature range given above and reaction of the reaction mixture thus obtained with the solution of a guanidine salt and alkali hydroxide or alkali alkanolate in a lower alcohol.
Es wurde nun gefunden, daß man zu neuen, in 5-Stellung substituierten 2-Aminopyrimidinen der allgemeinen Formel I gelangt, worin R jedoch eine Alkylgruppe bedeutet, die durch ein oder mehrere Sauerstoffatome unterbrochen und/oder ringgeschlossen ist, durch Umsetzung gemäß Patent 1145 622 unter Verwendung von Verbindungen der allgemeinen Formel II, worin jedoch R eine Alkylgruppe bedeutet, die durch ein oder mehrere Sauerstoffatome unterbrochen und/oder ringgeschlossen ist, und R' eine niedere Alkylgruppe bedeutet, an Stelle der beim Hauptpatent als Ausgangsstoffe dienenden 1,1,2-Trialkoxyäthane. It has now been found that new 2-aminopyrimidines substituted in the 5-position can be obtained general formula I arrives, in which R, however, is an alkyl group which is replaced by one or more Oxygen atoms is interrupted and / or ring-closed, by reaction according to patent 1145 622 using compounds of the general formula II, in which, however, R is an alkyl group, which is interrupted and / or ring-closed by one or more oxygen atoms, and R 'is a means lower alkyl group, instead of the 1,1,2-trialkoxyethanes used as starting materials in the main patent.
252 g Methoxyäthoxyacetaldehyd-di-methoxyäthylacetal
werden unter Rühren, Eiskühlung und Feuchtigkeitsausschluß langsam mit 210 g Phosphorpenta-Verfahren
zur Herstellung von in 5-Stellung
substituierten 2-Ammopyrimidinen252 g of methoxyethoxyacetaldehyde-dimethoxyethylacetal are slowly mixed with 210 g of phosphorus penta process for the preparation of in 5-position with stirring, ice-cooling and exclusion of moisture
substituted 2-ammopyrimidines
Zusatz zum Patent: 1145 622Addendum to the patent: 1145 622
worin R die oben angegebene Bedeutung hat und R' die Bedeutung von R hat, mit einem für die Vilsmeier-Reaktion geeigneten sauren, halogenhaltigen Kondensationsmittel in der Weise, daß ein Austausch einer der beiden Alkoxygruppen gegen Halogen erfolgt, ao und gleichzeitige oder anschließende Zugabe eines Formamide der allgemeinen Formelwherein R has the meaning given above and R 'has the meaning of R, with one for the Vilsmeier reaction suitable acidic, halogen-containing condensation agents in such a way that an exchange of a of the two alkoxy groups against halogen, ao and simultaneous or subsequent addition of one Formamides of the general formula
Anmelder:Applicant:
Schering Aktiengesellschaft,Schering Aktiengesellschaft,
Berlin N 65, Müllerstr. 170/172Berlin N 65, Müllerstr. 170/172
Als Erfinder benannt:Named as inventor:
Dr. Hans Priewe,Dr. Hans Priewe,
Dr. Klaus Gutsche, BerlinDr. Klaus Gutsche, Berlin
chlorid versetzt, so daß die Reaktionstemperatur 250C nicht übersteigt, und danach 30 Minuten bei Raumtemperatur gerührt. Anschließend werden 225 ml Dimethylformamid eingetropft, wobei durch Eiskühlung die Reaktionstemperatur auf 20 bis 25° C gehalten wird. Danach wird etwa 70 Minuten auf 6O0C erwärmt. Nach Abkühlen wird in das Reaktionsgemisch unter Eiskühlung 500 ml Methanol eingetropft, wobei die Reaktionstemperatur 20 bis 25° C nicht übersteigen soll. Anschließend wird die Reaktionslösung, ebenfalls unter Kühlung, bei einer Reaktionstemperatur von 20 bis 250C in eine Suspension aus 240 g gepulvertem Ätznatron und 800 ml Methanol getropft und 30 Minuten bei Raumtemperatur gerührt. Zu dem nunmehr neben anorganischen Salzen in der Lösung vorliegenden ^-Dimethylaminooc-methoxyäthoxyacrolein werden jetzt 200 g Guanidinnitrat und anschließend 70 g Ätznatron gegeben. Danach wird das Methanol unter Rühren abdestilliert. Der Destillationsrückstand wird in 1,51 Wasser gelöst und mehrfach mit Chloroform extrahiert. Die vereinigten Extrakte werden bis zur Trockne eingeengt. Der Destillationsrückstand ergibt nach Umkristallisation aus Tetrachlorkohlenstoff 80 g 2-Amino-5-methoxyäthoxypyrimidin; Fp. 80 bis 8I0C.chloride added so that the reaction temperature does not exceed 25 0 C, and then stirred for 30 minutes at room temperature. 225 ml of dimethylformamide are then added dropwise, the reaction temperature being kept at 20 to 25 ° C. by cooling with ice. Thereafter, about 70 minutes to 6O 0 C is heated. After cooling, 500 ml of methanol are added dropwise to the reaction mixture while cooling with ice, the reaction temperature not exceeding 20 to 25 ° C. The reaction solution is then added dropwise, likewise with cooling, at a reaction temperature of 20 to 25 ° C. in a suspension of 240 g of powdered caustic soda and 800 ml of methanol and stirred for 30 minutes at room temperature. 200 g of guanidine nitrate and then 70 g of caustic soda are now added to the ^ -dimethylaminooc-methoxyethoxyacrolein now present in the solution in addition to inorganic salts. The methanol is then distilled off with stirring. The distillation residue is dissolved in 1.5 liters of water and extracted several times with chloroform. The combined extracts are concentrated to dryness. After recrystallization from carbon tetrachloride, the distillation residue gives 80 g of 2-amino-5-methoxyethoxypyrimidine; Mp. 80 to 8I 0 C.
In analoger Weise werden aus 324 g 1,1,3-Tricyclohexyloxyäthan 88 g 2-AmInO-S-CyClOhCXyIoXyPyHnU-din, Fp. 72 bis 730C, erhalten.In an analogous manner, 88 g of 2-amino-S-CyClOhCXyIoXyPyHnU-din, mp be 72-73 0 C, obtained from 324 g of 1,1,3-Tricyclohexyloxyäthan..
609 560/474609 560/474
IOIO
B e is ρ i e13B e is ρ i e13
430 g Äthoxyäthoxyäthoxyacetaldehyd-di-äthoxyathoxyäthylacetal werden analog Beispiel 1 mit Phosphorpentachlorid, Dimethylformamid und Guanidinnitrat umgesetzt. Die aus dem Chloroformextrakt erhaltene Rohbase wird zur Reinigung in verdünnter Salzsäure gelöst und mehrfach mit Äther extrahiert. Anschließend wird die wäßrige Phase mit Natronlauge alkalisch gemacht und mit Chloroform extrahiert. Durch Einengen der Chloroformextrakte werden 175 g 2-Armno-5-äthoxyäthoxyäthoxypyrimidin als braunes Öl erhalten.430 g of ethoxyethoxyethoxyacetaldehyde di-ethoxyathoxyethyl acetal are analogous to Example 1 with phosphorus pentachloride, dimethylformamide and guanidine nitrate implemented. The crude base obtained from the chloroform extract is diluted in for purification Dissolved hydrochloric acid and extracted several times with ether. The aqueous phase is then washed with sodium hydroxide solution made alkaline and extracted with chloroform. Concentration of the chloroform extracts gives 175 g 2-Armno-5-ethoxyethoxyethoxypyrimidine was obtained as a brown oil.
Identifiziert wird die Base als Benzolsulf onylverbindung (Fp. 118 bis 119 0C), die durch Reaktion der *5 Base mit Benzolsulfonylchlorid in Pyridin dargestellt wird. 'The base as Benzolsulf onylverbindung (mp. 118-119 0 C), which is represented by the reaction * 5 Base with benzenesulfonyl chloride in pyridine is identified. '
B ei spiel 4Eg game 4
Analog Beispiel 3 werden aus 330 g Tetrahydrofurfuryloxyacetaldehyd - di - tetrahydrofurfurylacetal 130 g 2-Amino-5-tetrahydrodfurfuryloxypyrimidin als braunes Öl erhalten. Die zur Identifizierung der Base hergestellte Benzolsulf onylverbindung schmilzt bei 213 bis215°C.Analogously to Example 3, from 330 g of tetrahydrofurfuryloxyacetaldehyde - di - tetrahydrofurfurylacetal 130 g of 2-amino-5-tetrahydrodfurfuryloxypyrimidine as brown oil obtained. The benzenesulfonyl compound made to identify the base melts at 213 up to 215 ° C.
B ei sρi el 5Example 5
In eine Lösung von 30 g 1,1,3-Triäthoxyäthoxyäthan (hergestellt aus Chloracetaldehyddiäthoxyäthylacetal durch Umsetzung mit der Natriumverbindung des Äthylenglykolmonoäthyläthers; Kp.u = 17O0C) in 100 ml Methylenchlorid werden bei 30°C 27,5 g Phosgen eingeleitet. Dann werden in die abgekühlte Lösung bei — 5°C 23 ml Dimethylformamid eingetropft. Anschließend wird das Gemisch noch 1 Stunde bei gleieher Temperatur nachgerührt und dann auf 7O0C erhitzt. Dabei destilliert das Methylenchlorid ab. Danach wird das Gemisch noch etwa 3/4 Stunden bei 65 0C gehalten. Dem dann auf 200C abgekühlten Reaktionsgemisch werden unter Kühlung nacheinander 120 ml Methanol, 20 g Guanidinnitrat und 30 g Natriumhydroxyd eingetragen. Schließlich wird das Methanol unter Rühren abdestilliert und der Destillationsrückstand mit Perchloräthylen erschöpfend extrahiert. Die vereinigten Extrakte werden eingedampft und der Rückstand aus Tetrachlorkohlenstoff umkristallisiert. Man erhält so 12 g 2-Amino-5-äthoxyäthoxypyrimidin vom Schmelzpunkt 47 bis 49° C.In a solution of 30 g 1,1,3-Triäthoxyäthoxyäthan (made of Chloracetaldehyddiäthoxyäthylacetal by reaction with the sodium compound of Äthylenglykolmonoäthyläthers;. Kp u = 17O 0 C) in 100 ml of methylene chloride are introduced 27.5 g of phosgene at 30 ° C. Then 23 ml of dimethylformamide are added dropwise to the cooled solution at -5 ° C. The mixture is then stirred for a further 1 hour at moving rather temperature and then heated to 7O 0 C. The methylene chloride distills off. Thereafter, the mixture is kept for about 3/4 hours at 65 0 C. 120 ml of methanol, 20 g of guanidine nitrate and 30 g of sodium hydroxide are added in succession to the reaction mixture, which is then cooled to 20 ° C., while cooling. Finally, the methanol is distilled off with stirring and the distillation residue is exhaustively extracted with perchlorethylene. The combined extracts are evaporated and the residue is recrystallized from carbon tetrachloride. This gives 12 g of 2-amino-5-ethoxyethoxypyrimidine with a melting point of 47 to 49 ° C.
Analog Beispiel 5 erhält man aus 34 g 1,1,3-Triisopropoxyäthoxyäthan (hergestellt aus Chloracetaldehyddiisopropoxyäthylacetal und der Natriumverbindung des Äthylenglykolmonoisopropyläthers; Kp.2 = 1500C) 13 g 2-Armno-5-isopropoxyäthoxypyrimidin; Fp. etwa 350C, Kp.0l01 = 135 bis 1400C.(Kp = 150 2 0 C made of Chloracetaldehyddiisopropoxyäthylacetal and the sodium compound of Äthylenglykolmonoisopropyläthers.) 13 g of 2-Armno-5-isopropoxyäthoxypyrimidin analogously to Example 5, from 34 g of 1,1,3-Triisopropoxyäthoxyäthan; Fp. About 35 ° C., b.p. 0 l 01 = 135 to 140 ° C.
Claims (1)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DESCH29319A DE1215161B (en) | 1961-02-22 | 1961-03-02 | Process for the preparation of 2-aminopyrimidines substituted in the 5-position |
CH1003666A CH433344A (en) | 1960-10-18 | 1961-10-10 | Process for the preparation of new 2-aminopyrimidines |
CH1171261A CH421115A (en) | 1960-10-18 | 1961-10-10 | Process for the production of new sulfonamides and their salts |
GB824764A GB997632A (en) | 1961-03-02 | 1961-10-12 | New pyrimidines and process for their manufacture |
DK407961A DK106851C (en) | 1960-10-18 | 1961-10-13 | Process for the preparation of sulfonamidopyrimidines or salts thereof. |
DK346063A DK106800C (en) | 1960-10-18 | 1961-10-13 | Process for the preparation of sulfonamidopyrimidines or salts thereof. |
DK345963A DK107097C (en) | 1960-10-18 | 1961-10-13 | Process for the preparation of sulfonamidopyrimidines or salts thereof. |
DK345863A DK106852C (en) | 1960-10-18 | 1961-10-13 | Process for the preparation of sulfonamidopyrimidines or salts thereof. |
NL61270346A NL139314B (en) | 1960-10-18 | 1961-10-18 | METHOD OF PREPARING A SULPHONAMIDE AND A BLOOD SUGAR-MIRROR-LOWERING MEDICINAL PRODUCT. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1961SC029273 DE1445142B2 (en) | 1960-10-18 | 1961-02-22 | 2- (BENZOLSULFONAMIDO) -5-METHOXYAETHOXY-PYRIMIDINE DERIVATIVES |
DESCH29319A DE1215161B (en) | 1961-02-22 | 1961-03-02 | Process for the preparation of 2-aminopyrimidines substituted in the 5-position |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1215161B true DE1215161B (en) | 1966-04-28 |
Family
ID=25992904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DESCH29319A Pending DE1215161B (en) | 1960-10-18 | 1961-03-02 | Process for the preparation of 2-aminopyrimidines substituted in the 5-position |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE1215161B (en) |
-
1961
- 1961-03-02 DE DESCH29319A patent/DE1215161B/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1302858B (en) | ||
DE1240846B (en) | Process for the preparation of sulfamides | |
DE1169939B (en) | Process for the preparation of dihalo-aminobenzylamines or their acid addition salts with physiologically acceptable acids | |
AT200578B (en) | Process for the preparation of new N-aminoalkyl derivatives of azepines | |
DE2609015C2 (en) | Process for the preparation of Benz (f) -2,5-oxazocines | |
DE1215161B (en) | Process for the preparation of 2-aminopyrimidines substituted in the 5-position | |
DE2101997A1 (en) | 1-benzyl-4-subst-tetrahydropyridines - useful as intermediates for pharmaceuticals | |
DE1150991B (en) | Process for the preparation of 7-sulfamyl-3, 4-dihydro-1, 2, 4-benzothiadiazine-1, 1-dioxydes | |
DE2258239A1 (en) | Cinnamic and dihydrocinnamic acid derivs - used as starting materials for antibacterial 2,4-diamino-5-benzylpyrimidines | |
DE1670478A1 (en) | Process for the preparation of derivatives of alpha-piperazino-phenylacetonitrile | |
DE2620777A1 (en) | 1-Hydroxy benzo 2,3,1-diaza borines - gram negative antibacterials prepd from formyl phenyl boric acid and sulphonic acid hydroazide | |
DE1670168A1 (en) | Process for the production of new antidiabetic sulfonamides | |
DE1966132B2 (en) | 7-chloro-2-hydroxy-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine | |
DE1720012C3 (en) | Process for the preparation of 2,4-diamino-5- (3,4,5-trimethoxybenzyl) pyrimidine | |
DE2258238A1 (en) | 5-Benzylpyrimidines prepn - from benzaldehyde and cyanoacetic acid ester via 2,4-diamino-5-benzyl-6-hydroxypyrimidine | |
CH507961A (en) | Antidiabetic sulphonamides | |
DE860066C (en) | Process for the preparation of ketoamino alcohol derivatives | |
AT287726B (en) | Process for the preparation of new 1H-thieno- [3,2-e] -1,4-diazepin-2-ones and their N-oxides and salts | |
AT332423B (en) | PROCESS FOR MANUFACTURING NEW PYRIDYLTHIOURA | |
DE856297C (en) | Process for the production of 3- (2-oxy-phenyl) -pyrazole or its substitution products | |
DE1720012B2 (en) | Process for the preparation of 2,4-DIAMINO-5- (3,4,5-TRIMETHOXYBENZYL) -PYRIMIDINE | |
DE1470283C (en) | 1-methyl-5-sulfanilamido-pyridazone (6) derivatives | |
AT236950B (en) | Process for the production of new triazolidines | |
AT223195B (en) | Process for the preparation of new 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes | |
AT234706B (en) | Process for the preparation of sulfonamides |